Federation des caisses Desjardins du Quebec’s Matinas BioPharma MTNB Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-306	Closed	-$11.9K	–	2593
2021 Q2	$11.9K	Hold	306	–	–	﹤0.01%	2017
2021 Q1	$16.1K	Hold	306	–	–	﹤0.01%	1868
2020 Q4	$20.8K	Buy	+306	New	+$14.2K	﹤0.01%	1735

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCM

Courage Capital Management Nashville, Tennessee $70.6M AUM 13.29% 1-Year Est. Return

AWA

Arkadios Wealth Advisors Atlanta, Georgia $6.13B AUM 23.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's MTNB Position: Q3 2021 in Review

Federation des caisses Desjardins du Quebec sold out of Matinas BioPharma (MTNB) in Q3 2021, closing a stake of 306 shares — an estimated $11.9K sold.

Federation des caisses Desjardins du Quebec first reported a position in MTNB in Q4 2020 and held it in 3 quarters. The position peaked at $20.8K in Q4 2020. 67 funds tracked by Wall St. Rank hold MTNB as of Q3 2021.

Federation des caisses Desjardins du Quebec reported no remaining Matinas BioPharma position as of Q3 2021 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 306 Matinas BioPharma shares in Q3 2021, an estimated $11.9K.
Federation des caisses Desjardins du Quebec first reported a position in Matinas BioPharma in Q4 2020 and held it in 3 quarters.
Federation des caisses Desjardins du Quebec's Matinas BioPharma position peaked at $20.8K in Q4 2020.
67 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2021.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2021, filed 30 Aug 2024.